Shanghai HeartCare Medical Technology (HKSE:06609) Cash per Share : HK$20.31 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Shanghai HeartCare Medical Technology Cash per Share?

Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities divided by Shares Outstanding (EOP). Shanghai HeartCare Medical Technology's Cash per Share for the quarter that ended in Dec. 2023 was HK$20.31.

Shanghai HeartCare Medical Technology Cash per Share Historical Data

The historical data trend for Shanghai HeartCare Medical Technology's Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai HeartCare Medical Technology Cash per Share Chart

Shanghai HeartCare Medical Technology Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Cash per Share

1.60

19.31

38.40

25.02

20.31

Shanghai HeartCare Medical Technology Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Cash per Share	Get a 7-Day Free Trial				38.40	30.11	25.02	20.98	20.31

Shanghai HeartCare Medical Technology Cash per Share Calculation

This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.

Shanghai HeartCare Medical Technology's Cash per Share for the fiscal year that ended in Dec. 2023 is calculated as:

Cash per Share	=	Cash, Cash Equivalents, Marketable Securities	/	Shares Outstanding (EOP)
	=	788.767	/	38.8
	=	20.31

Shanghai HeartCare Medical Technology's Cash per Share for the quarter that ended in Dec. 2023 is calculated as:

Cash per Share	=	Cash, Cash Equivalents, Marketable Securities	/	Shares Outstanding (EOP)
	=	788.767	/	38.8
	=	20.31

Shanghai HeartCare Medical Technology (HKSE:06609) Cash per Share Explanation

Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.

Shanghai HeartCare Medical Technology Cash per Share Related Terms

Thank you for viewing the detailed overview of Shanghai HeartCare Medical Technology's Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai HeartCare Medical Technology (HKSE:06609) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shanghai HeartCare Medical Technology Corp Ltd (HKSE:06609) » Definitions » Cash per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 356, Zhengbo Road, Floor 1 and 3, Building 38, Pilot Free Trade Zone, Lingang New District, Shanghai, CHN

Website

http://www.strokemedical.com

Shanghai HeartCare Medical Technology Corp Ltd is an innovative neuro-interventional medical device company. The company is committed to creating high-quality products for the prevention and treatment of stroke. Geographically, the Group's revenue is derived from Mainland China.

Executives

Ding Kui	2201 Interest of corporation controlled by you
Wisary Limited	2101 Beneficial owner
Wang Guohui
Shanghai Zandaqian Enterprise Management Consulting Center
Lyfe Capital Management Limited
Lyfe Capital Fund Iii (dragon), L.p.
Shanghai Weiyun Enterprise Management Consulting Partnership (lp)
Lyfe Columbia River Limited
Temasek Holdings (private) Limited
Elbrus Investments Pte. Ltd.
Fullerton Management Pte Ltd
Temasek Life Sciences Private Limited

Shanghai HeartCare Medical Technology (HKSE:06609) Headlines

No Headlines